Marco Vignetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
COMPLEX KARYOTYPE IS ASSOCIATED WITH A LESS FAVORABLE OUTCOME AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114).	HemaSphere 2020; 4 (S1) p 290	2020
COMPLEX KARYOTYPE AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114)	Haematologica, 2020; 105(s2):s28	2020
Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults	NEW ENGLAND JOURNAL OF MEDICINE	2020
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy	LEUKEMIA	2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index	LEUKEMIA	2020
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial	LEUKEMIA	2020
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning	BRITISH JOURNAL OF HAEMATOLOGY	2020
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey	LEUKEMIA	2020
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey	LEUKEMIA	2020
The prognostic value of patient-reported outcomes (PROs) for survival outcomes in cancer patients: A systematic review	JOURNAL OF CLINICAL ONCOLOGY	2019
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.	BLOOD	2019
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies	VALUE IN HEALTH	2019
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial	LEUKEMIA	2019
Quality of life and CAR-T cell therapy in children, adolescents, and young adults with haematological malignancies	THE LANCET ONCOLOGY	2019
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy	LEUKEMIA	2019
Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative	AMERICAN JOURNAL OF HEMATOLOGY	2019
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol	LEUKEMIA & LYMPHOMA	2019
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients	HAEMATOLOGICA	2019
Francesco Lo Coco, a distinguished hematologist and a friend	HAEMATOLOGICA	2019
Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia	LEUKEMIA	2019